Home » Topics » BioWorld Science

BioWorld Science
RSS

SUMOylation inhibition enhances targeting of farnesoid X receptor for liver fibrosis

Jan. 20, 2020

Xalud starts phase II study of XT-150 for pain due to knee osteoarthritis

Jan. 20, 2020

Pfizer begins phase III study of PF-06801591 in high-risk nonmuscle invasive bladder cancer

Jan. 20, 2020

New compounds for Huntington's disease presented by PTC Therapeutics

Jan. 20, 2020

Meiji Seika Pharma describes new PDE4 inhibitors

Jan. 20, 2020

AlzeCure Pharma presents Trk-A and/or Trk-B and/or Trk-C modulators

Jan. 20, 2020

Single transcription factor enables chronic toxoplasma infection

Jan. 20, 2020

B cells help T cells succeed during checkpoint blockade

Jan. 20, 2020

Roche discloses new EGFR mutant inhibitors

Jan. 20, 2020

Suzhou Mednes Pharma Tech patents hedgehog signaling inhibitors

Jan. 20, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 26, 2026.
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...